Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_provenance.
- NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_assertion description "[The prevalence and uniformity of FSIP1 expression in breast tumors, taken together with the highly restricted expression in normal tissues, suggests that FSIP1 may be an attractive target for breast cancer immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_provenance.
- NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_assertion evidence source_evidence_literature NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_provenance.
- NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_assertion SIO_000772 23905897 NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_provenance.
- NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_assertion wasDerivedFrom befree-2016 NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_provenance.
- NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_assertion wasGeneratedBy ECO_0000203 NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_provenance.
- befree-2016 importedOn "2016-02-19" NP1098642.RAvOE7v0GrQ-avU-3dEuKyQ6bPEBW0VlCKvwQyYzrc8Go130_provenance.